JP5581056B2 - ゼラチン−トランスグルタミナーゼ止血ドレッシング及びシーラント - Google Patents

ゼラチン−トランスグルタミナーゼ止血ドレッシング及びシーラント Download PDF

Info

Publication number
JP5581056B2
JP5581056B2 JP2009541417A JP2009541417A JP5581056B2 JP 5581056 B2 JP5581056 B2 JP 5581056B2 JP 2009541417 A JP2009541417 A JP 2009541417A JP 2009541417 A JP2009541417 A JP 2009541417A JP 5581056 B2 JP5581056 B2 JP 5581056B2
Authority
JP
Japan
Prior art keywords
gelatin
solution
transglutaminase
mtg
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2009541417A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010521994A (ja
JP2010521994A5 (https=
Inventor
プライス−ブルーム，オルハン
アタル，イシャイ
イラム，ナタリー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lifebond Ltd
Original Assignee
Lifebond Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39290740&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP5581056(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lifebond Ltd filed Critical Lifebond Ltd
Publication of JP2010521994A publication Critical patent/JP2010521994A/ja
Publication of JP2010521994A5 publication Critical patent/JP2010521994A5/ja
Application granted granted Critical
Publication of JP5581056B2 publication Critical patent/JP5581056B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/50—Lubricants; Anti-adhesive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/38—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A61L15/585—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/104—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0038—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Surgical Instruments (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2009541417A 2006-12-15 2007-12-17 ゼラチン−トランスグルタミナーゼ止血ドレッシング及びシーラント Active JP5581056B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US87515006P 2006-12-15 2006-12-15
US60/875,150 2006-12-15
US88707P 2007-10-30 2007-10-30
US61/000,887 2007-10-30
PCT/US2007/025726 WO2008076407A2 (en) 2006-12-15 2007-12-17 Gelatin-transglutaminase hemostatic dressings and sealants

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011267107A Division JP5993571B2 (ja) 2006-12-15 2011-12-06 ゼラチン−トランスグルタミナーゼ止血ドレッシング及びシーラント

Publications (3)

Publication Number Publication Date
JP2010521994A JP2010521994A (ja) 2010-07-01
JP2010521994A5 JP2010521994A5 (https=) 2013-05-23
JP5581056B2 true JP5581056B2 (ja) 2014-08-27

Family

ID=39290740

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009541417A Active JP5581056B2 (ja) 2006-12-15 2007-12-17 ゼラチン−トランスグルタミナーゼ止血ドレッシング及びシーラント
JP2011267107A Active JP5993571B2 (ja) 2006-12-15 2011-12-06 ゼラチン−トランスグルタミナーゼ止血ドレッシング及びシーラント

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011267107A Active JP5993571B2 (ja) 2006-12-15 2011-12-06 ゼラチン−トランスグルタミナーゼ止血ドレッシング及びシーラント

Country Status (11)

Country Link
US (4) US9017664B2 (https=)
EP (1) EP2111239B1 (https=)
JP (2) JP5581056B2 (https=)
KR (1) KR101428122B1 (https=)
CN (3) CN102552967B (https=)
AU (1) AU2007334394B2 (https=)
BR (1) BRPI0718328A2 (https=)
CA (1) CA2672651C (https=)
MX (1) MX2009006369A (https=)
RU (1) RU2464015C2 (https=)
WO (1) WO2008076407A2 (https=)

Families Citing this family (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0718328A2 (pt) 2006-12-15 2011-10-11 Lifebond Ltd composição, curativo hemostático e dispositivo médico para a inserção em um corpo de um ser humano ou de um mamìfero inferior
ES2555204T3 (es) 2007-11-21 2015-12-29 T.J. Smith & Nephew Limited Dispositivo de succión y venda
GB0722820D0 (en) 2007-11-21 2008-01-02 Smith & Nephew Vacuum assisted wound dressing
ES2776709T3 (es) 2007-11-21 2020-07-31 Smith & Nephew Apósito para heridas
US20130096518A1 (en) 2007-12-06 2013-04-18 Smith & Nephew Plc Wound filling apparatuses and methods
GB0723875D0 (en) 2007-12-06 2008-01-16 Smith & Nephew Wound management
US11253399B2 (en) 2007-12-06 2022-02-22 Smith & Nephew Plc Wound filling apparatuses and methods
GB0803564D0 (en) 2008-02-27 2008-04-02 Smith & Nephew Fluid collection
CA2716872C (en) 2008-02-29 2015-02-10 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US20100008989A1 (en) * 2008-06-12 2010-01-14 Ishay Attar Process for manufacture of gelatin solutions and products thereof
WO2009153748A2 (en) * 2008-06-18 2009-12-23 Lifebond Ltd Methods and devices for use with sealants
EP2487206A3 (en) * 2008-06-18 2012-11-28 Lifebond Ltd Cross-linkable gelatin-based compositions
AU2014201672B2 (en) * 2008-06-18 2015-05-21 Lifebond Ltd Improved cross-linked compositions
WO2010002435A2 (en) * 2008-07-03 2010-01-07 Kulinets Irina B Hemostatic pouch and method to stabilize hemostatic components
US8241654B2 (en) * 2008-09-26 2012-08-14 Tyco Healthcare Group Lp Reactive surgical implant
WO2010065908A2 (en) * 2008-12-05 2010-06-10 Catchmark Jeffrey M Degradable biomolecule compositions
GB0902816D0 (en) 2009-02-19 2009-04-08 Smith & Nephew Fluid communication path
US8314211B2 (en) * 2009-04-07 2012-11-20 George Falus Tissue sealant for use in non compressible hemorrhage
EP2442834A2 (en) * 2009-06-15 2012-04-25 Technion Research and Development Foundation, Ltd. Reinforced surgical adhesives and sealants and their in-situ application
KR101114773B1 (ko) * 2009-10-23 2012-03-05 세원셀론텍(주) 연골조직 수복용 조성물의 제조방법
WO2011077388A1 (en) * 2009-12-22 2011-06-30 Lifebond Ltd Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
US9061095B2 (en) 2010-04-27 2015-06-23 Smith & Nephew Plc Wound dressing and method of use
GB201011173D0 (en) 2010-07-02 2010-08-18 Smith & Nephew Provision of wound filler
US8961544B2 (en) * 2010-08-05 2015-02-24 Lifebond Ltd. Dry composition wound dressings and adhesives comprising gelatin and transglutaminase in a cross-linked matrix
JP2012095769A (ja) * 2010-10-29 2012-05-24 Gunze Ltd 医療用接着剤及び医療用材料
GB201020005D0 (en) 2010-11-25 2011-01-12 Smith & Nephew Composition 1-1
JP6078472B2 (ja) 2010-11-25 2017-02-08 スミス アンド ネフュー ピーエルシーＳｍｉｔｈ ＆ Ｎｅｐｈｅｗ Ｐｕｂｌｉｃ Ｌｉｍｉｔｅｄ Ｃｏｍｐａｎｙ 組成物ｉ−ｉｉおよび生成物ならびにそれらの使用
CN104136602B (zh) * 2011-06-23 2017-06-09 成功大学 细胞组织胶黏剂
US9149511B2 (en) 2011-06-30 2015-10-06 Ethicon, Inc. Procoagulant peptides and their derivatives and uses therefor
WO2013045689A1 (en) 2011-09-29 2013-04-04 BIORIGEN Srl Therapeutic use of gelatin hydrogels with a gel-sol transition at body temperature
EP2574349A1 (en) * 2011-09-29 2013-04-03 Biorigen S.r.l Therapeutic use of gelatin hydrogels with a gel-sol transition at body temperature
SG11201401878SA (en) 2011-10-27 2014-09-26 Baxter Int Hemostatic compositions
WO2013060769A2 (en) 2011-10-27 2013-05-02 Baxter International Inc. Hemostatic compositions
US20150159066A1 (en) 2011-11-25 2015-06-11 Smith & Nephew Plc Composition, apparatus, kit and method and uses thereof
GB201201751D0 (en) * 2012-02-01 2012-03-14 Haemostatix Ltd Haemostatic wound dressing
CN104159527B (zh) 2012-03-06 2017-04-12 弗罗桑医疗设备公司 包含止血糊剂的压力容器
RU2636240C2 (ru) * 2012-06-12 2017-11-21 Ферросан Медикал Дивайсиз А/С Сухая гемостатическая композиция
US10888375B2 (en) 2012-07-06 2021-01-12 The General Hospital Corporation Method and apparatus for dermatological treatment
EP2872216B1 (en) * 2012-07-06 2022-02-23 The General Hospital Corporation Method and apparatus for dermatological treatment
CN102824654B (zh) * 2012-09-11 2014-07-02 武汉理工大学 一种采用双生物酶修饰的明胶与壳聚糖共混生物材料及其制备方法与应用
US8680240B1 (en) * 2012-11-01 2014-03-25 George David Falus Tissue sealant for use in non-compressible hemorrhage
US9212357B2 (en) 2012-12-03 2015-12-15 Omrix Biopharmaceuticals Ltd. Thrombin solution and methods of use thereof
EP2946795B1 (en) 2013-01-18 2019-04-17 National Institute for Materials Science Tissue adhesive and process for producing same
US9446166B2 (en) 2013-01-24 2016-09-20 Ethicon, Inc. Fibrin sealant compositions with chemical crosslinking
WO2014160377A1 (en) * 2013-03-13 2014-10-02 Invivo Therapeutics Corporation Crosslinkable trehalose for the covalent incorporation in hydrogels and methods of use
US20160120706A1 (en) 2013-03-15 2016-05-05 Smith & Nephew Plc Wound dressing sealant and use thereof
EP2968647B1 (en) 2013-03-15 2022-06-29 Smith & Nephew plc Wound dressing sealant and use thereof
CN103263688B (zh) * 2013-05-10 2014-07-30 华东师范大学 一种明胶组合物及其制备方法和应用
JP6390873B2 (ja) * 2013-06-21 2018-09-19 フェッローサン メディカル ディバイス エー／エス 減圧膨張させた乾燥組成物およびそれを保持するためのシリンジ
JP6413228B2 (ja) * 2013-11-13 2018-10-31 東ソー株式会社 長期保存可能な核酸増幅試薬
BR112016013322B1 (pt) 2013-12-11 2020-07-21 Ferrosan Medical Devices A/S métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit
US20160000985A1 (en) * 2014-07-02 2016-01-07 Abbott Cardiovascular Systems Inc. Extravascular devices supporting an arteriovenous fistula
BR112017007466B1 (pt) 2014-10-13 2021-03-02 Ferrosan Medical Devices A/S método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
KR101694121B1 (ko) * 2014-10-28 2017-01-10 (주)헵틸와이 이중 가교구조의 생체친화형 다공성 시트 및 그 제조방법
US9801983B2 (en) 2014-12-18 2017-10-31 Cook Medical Technologies Llc Medical devices for delivering a bioactive to a point of treatment and methods of making medical devices
JP2017538751A (ja) 2014-12-19 2017-12-28 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 流動性止血組成物
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
EP3277307B1 (en) * 2015-04-03 2021-12-08 Biochange Ltd. Powder compositions for generating cross-linked protein foams and methods of using thereof
CA2986981A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
US10751444B2 (en) 2015-08-07 2020-08-25 Victor Matthew Phillips Flowable hemostatic gel composition and its methods of use
US10660945B2 (en) 2015-08-07 2020-05-26 Victor Matthew Phillips Flowable hemostatic gel composition and its methods of use
CN105688269B (zh) * 2016-02-03 2021-04-16 广州迈普再生医学科技股份有限公司 一种改性明胶止血材料及其制备方法
CN109475400A (zh) * 2016-05-09 2019-03-15 生命连结有限公司 基于网状补片的原位可交联组合物
CN107349462B (zh) * 2016-05-09 2020-07-14 北京纳什国际生物科技有限公司 一种可吸收半流动性交联多肽生物外科止血物
GB201614053D0 (en) * 2016-08-17 2016-09-28 Microarray Ltd Determining the condition of a wound
WO2018067938A1 (en) * 2016-10-06 2018-04-12 The Trustees Of Columbia University In The City Of New York Cell-seeded porous lung hydrogel sealant
JP2019216755A (ja) 2016-10-26 2019-12-26 国立研究開発法人物質・材料研究機構 止血材
JP6904550B2 (ja) * 2016-11-04 2021-07-21 青葉化成株式会社 食品用品質改良材の製造方法
CN106729957B (zh) * 2016-12-12 2020-06-09 西北大学 一种以谷氨酰胺转移酶为交联剂的体内止血敷料的制备方法
EP3573675A1 (en) * 2017-01-30 2019-12-04 LifeCell Corporation Tissue matrix materials and enzymatic adhesives
EP3573674A1 (en) * 2017-01-30 2019-12-04 LifeCell Corporation Transglutaminase treated products
AU2018230356A1 (en) * 2017-03-08 2019-10-24 Baxter Healthcare Sa Device for delivery of powdered hemostatic agents
CN107296636B (zh) * 2017-05-10 2024-04-02 中国人民解放军军事医学科学院卫生装备研究所 一种可注射用止血海绵装置、注射器及套件
WO2019003224A1 (en) * 2017-06-26 2019-01-03 Eyal Sheetrit ADHESIVE OF BIOCOMPATIBLE NANOFIBRES
CN111065421B (zh) * 2017-09-04 2022-04-29 国立研究开发法人物质·材料研究机构 含有交联明胶衍生物粒子的伤口敷料
EP3680330A4 (en) * 2017-09-07 2021-09-01 Amano Enzyme Inc. STABILIZED DRY PROTEIN EMIDASE COMPOSITION
JP7138702B2 (ja) 2017-09-22 2022-09-16 ベクトン・ディキンソン・アンド・カンパニー カテーテルロック溶液としての使用のための４％クエン酸三ナトリウム溶液
EP3687560A4 (en) * 2017-09-29 2021-06-23 Bard Shannon Limited COMPOSITION AND METHOD OF CONTROLLED DRUG RELEASE FROM TISSUE
KR20210062589A (ko) * 2017-10-04 2021-05-31 바이오-체인지 엘티디. 가교 결합된 단백질 발포체 및 다가 세포 스캐폴드 사용 방법
KR101989054B1 (ko) * 2017-11-28 2019-06-13 (주)다림티센 지혈용 조성물 및 이를 포함하는 용기
CN108114311A (zh) * 2017-12-20 2018-06-05 江苏省健尔康医用敷料有限公司 碘仿明胶海绵的制备方法
RU2689035C1 (ru) * 2017-12-25 2019-05-23 федеральное государственное бюджетное образовательное учреждение высшего образования "Хакасский государственный университет им. Н.Ф. Катанова" (ФГБОУ ВО ХГУ им. Н.Ф. Катанова) Способ лечения поверхностных плоскостных ран у животных
JP6960862B2 (ja) * 2018-01-15 2021-11-05 日本バイリーン株式会社 ゼラチン溶液と該ゼラチン溶液からなる紡糸液、および、該紡糸液を用いた繊維集合体の製造方法と該ゼラチン溶液を用いたフィルムならびに複合体の製造方法
WO2019172261A1 (ja) * 2018-03-05 2019-09-12 国立大学法人東京大学 食道狭窄防止材料
EP4321182A3 (en) 2018-05-09 2024-05-29 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition
CN108339150A (zh) * 2018-05-09 2018-07-31 浙江海洋大学 一种日本黄姑鱼鱼皮胶原蛋白/藻酸盐复合海绵的制备方法
US11998654B2 (en) * 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices
CN110917389B (zh) * 2018-09-20 2022-03-22 广州迈普再生医学科技股份有限公司 一种组织封闭组合物、组织封堵胶及其制备方法
JP7332125B2 (ja) * 2018-10-05 2023-08-23 青葉化成株式会社 粘弾性を有する天然高分子化合物組成物の製造方法
EP3873991A4 (en) 2018-11-02 2022-07-27 Covalon Technologies Inc. FOAM COMPOSITIONS, FOAM MATRICES AND PROCESSES
CN109200332A (zh) * 2018-11-26 2019-01-15 广州新诚生物科技有限公司 一种可生物降解的止血骨蜡及其制备方法
CN111249516B (zh) * 2018-12-01 2020-12-22 浙江大学 一种含胰蛋白酶的止血织物及其制备方法
CN111249518B (zh) * 2018-12-01 2021-03-05 浙江大学 一种止血组合物及其制备方法
CN109620999A (zh) * 2019-01-12 2019-04-16 王若梅 一种复合止血医用组织胶的制备方法
JP7303511B2 (ja) * 2019-02-18 2023-07-05 青葉化成株式会社 医療材料およびその製造方法
CN112494710B (zh) * 2019-09-16 2021-12-14 天津大学 一种转谷氨酰胺酶促交联的双网络粘合剂及其制备方法
CA3156813A1 (en) 2019-10-03 2021-04-08 Medcura, Inc. Hydrophobically-modified biopolymer materials
CN110665050B (zh) * 2019-11-08 2021-02-26 江南大学 一种生物粘合剂及其制备方法
JP2022035989A (ja) * 2020-08-20 2022-03-04 青葉化成株式会社 液状医療材料
EP3957338A1 (en) 2020-08-20 2022-02-23 Aobakasei Kabushiki Kaisha Liquid medical material
CN112915264A (zh) * 2021-01-21 2021-06-08 中国人民解放军空军军医大学 用于明胶-海藻酸钠-prp复合材料的制作方法
CN113181418B (zh) * 2021-04-09 2022-05-03 青岛大学附属医院 一种医用粘合剂及其制备方法
CN113521383A (zh) * 2021-07-29 2021-10-22 北京赛升药业股份有限公司 一种抗感染可吸收流体明胶止血材料及其制备方法
KR102717164B1 (ko) * 2021-08-17 2024-10-15 한스바이오메드 주식회사 지혈 조성물, 이를 포함하는 지혈 키트, 및 이의 제조 방법
CN114377189B (zh) * 2021-12-10 2023-04-07 广东省科学院健康医学研究所 一种止血复合水凝胶及其制备方法与应用
KR102527411B1 (ko) * 2022-02-08 2023-04-28 영남이공대학교 산학협력단 습윤 밴드용 조성물, 상기 습윤밴드 및 이의 제조방법
EP4572812A2 (en) * 2022-08-19 2025-06-25 Purdue Research Foundation Mussel-inspired tissue adhesives and methods of use thereof
WO2025176196A1 (zh) * 2024-02-23 2025-08-28 欧承健股份有限公司 凝胶、其制造方法及用途
KR102743315B1 (ko) * 2024-06-25 2024-12-16 주식회사 이노파마 카올린과 셀룰로오스를 혼합한 분사형 지혈제 제조방법 및 그에 따라 제조된 분사형 지혈제
CN118846203B (zh) * 2024-06-28 2025-09-16 山东科技大学 一种藻蓝蛋白-胶原蛋白复合水凝胶及其制备方法和应用

Family Cites Families (214)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2719145A (en) 1955-09-27 Process for effecting complex
US1873580A (en) 1932-08-23 Dustries limited
US1394654A (en) 1920-12-27 1921-10-25 Donald K Tressler Manufacture of liquid glue
US1844679A (en) 1925-12-07 1932-02-09 Glue Res Corp Glue solution and process of manufacturing same
US1950483A (en) * 1931-07-13 1934-03-13 Swift & Co Preparation of glue and the product thereof
US2048499A (en) 1934-04-07 1936-07-21 Deutsche Hydrierwerke Ag Gelatine solutions
US2166074A (en) 1937-04-09 1939-07-11 Sharp & Dohme Inc Gelatinous colloids
US2126305A (en) * 1937-06-23 1938-08-09 Eastman Kodak Co Dispersion of gelatin
US2417713A (en) * 1940-03-19 1947-03-18 Ilford Ltd Production of gelatin layers
US2398004A (en) 1943-07-20 1946-04-09 Eastman Kodak Co Controlling the isoelectric point of gelatin
US2558065A (en) 1949-05-03 1951-06-26 Linwood F Tice Method of preparing solutions of gelatin in polyhydric alcohols
US2658001A (en) 1950-09-26 1953-11-03 Swift & Co Liquid glue composition
US2803548A (en) 1955-02-07 1957-08-20 Louis Milani Foods Inc Method of making gelatin-containing food preparations which dissolve at room temperature and gel at room temperature
US3220845A (en) * 1963-04-10 1965-11-30 Keuffel & Esser Co Epoxy resin impregnated photo base and method of preparation
US3600482A (en) 1970-01-15 1971-08-17 Monsanto Res Corp Method of forming a mat of fibrous gelatin
US3939001A (en) 1973-06-08 1976-02-17 General Foods Corporation Spoonable frozen gelatin dessert concentrate
US3988479A (en) 1975-03-26 1976-10-26 Stephan John T Gelled proteinaceous fish bait and process of preparing same
US4188373A (en) 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
DE2612726C3 (de) 1976-03-25 1979-03-15 Boehringer Mannheim Gmbh, 6800 Mannheim Stabilisierte Urease
JPS5832576B2 (ja) 1976-10-28 1983-07-14 協和醗酵工業株式会社 ゼラチンの改質法
SE415804B (sv) 1978-06-21 1980-10-27 Nils Johannes Baecklund Sett att medelst rontgenstralning meta halten eller mengden av ett forutbestemt grundemne i ett prov, samt anordning for utforande av settet
US4426443A (en) 1981-08-27 1984-01-17 Dynagel, Incorporated Preparation of hydrolyzed collagen-containing products from non-gelled, liquid hydrolyzed collagen concentrate and gelled products prepared therefrom
US4527906A (en) * 1982-12-27 1985-07-09 Venda Jezbera Digital menstrual cycle indicator
US4478822A (en) 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
CA1202904A (en) 1983-11-21 1986-04-08 Brian G. Sparkes Chitosan based wound dressing materials
US4711848A (en) 1984-03-14 1987-12-08 Zymogenetics, Inc. Site specific mutagenesis in alpha-1-antitrypsin
US4605513A (en) 1984-08-08 1986-08-12 Eli Lilly And Company Process for inhibiting peptide carbamylation
JPS61240963A (ja) 1985-04-18 1986-10-27 ユニチカ株式会社 創傷被覆保護材
JPH0779694B2 (ja) 1985-07-09 1995-08-30 カドラント バイオリソ−シズ リミテツド 蛋白質および同類品の保護
FR2586030B1 (fr) 1985-08-07 1987-12-18 Rousselot Cie Gelatine a proprietes ameliorees et son procede de preparation par pelliculage avec une gelatine hydrolysee
JPS6323670A (ja) * 1986-04-25 1988-01-30 バイオ−ポリマ−ズ　インコ−ポレ−テツド 接着・被覆組成物とその使用方法
EP0302953A1 (de) 1987-08-11 1989-02-15 Deutsche Gelatine-Fabriken Stoess AG Verfahren zur Herrstellung von Formkörpern aus Kollagen und Kollagenabbauprodukten
US4952618A (en) 1988-05-03 1990-08-28 Minnesota Mining And Manufacturing Company Hydrocolloid/adhesive composition
US4837379A (en) 1988-06-02 1989-06-06 Organogenesis Inc. Fibrin-collagen tissue equivalents and methods for preparation thereof
GB8813161D0 (en) * 1988-06-03 1988-07-06 Unilever Plc Emulsions
US4948540A (en) 1988-08-01 1990-08-14 Semex Medical, Inc. Method of preparing collagen dressing sheet material
JPH02255888A (ja) * 1988-11-08 1990-10-16 Nippon Oil & Fats Co Ltd 架橋ゼラチンゲル
JP2719166B2 (ja) 1989-02-02 1998-02-25 鐘紡株式会社 毛髪化粧料組成物
US4931501A (en) 1989-10-20 1990-06-05 Air Products And Chemicals, Inc. Modified poly(vinyl alcohol) containing morpholinoalkylether groups
DE4007668A1 (de) 1990-03-10 1991-09-12 Beiersdorf Ag Hydrogelschaeume und verfahren zu deren herstellung
US5209776A (en) 1990-07-27 1993-05-11 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
US5059636A (en) 1990-11-13 1991-10-22 Grenga Paul A Tire sealant composition
US6197325B1 (en) * 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6559119B1 (en) * 1990-11-27 2003-05-06 Loyola University Of Chicago Method of preparing a tissue sealant-treated biomedical material
US6117425A (en) * 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US7229959B1 (en) * 1990-11-27 2007-06-12 The American National Red Cross Supplemented fibrin matrix delivery systems
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US5480644A (en) 1992-02-28 1996-01-02 Jsf Consultants Ltd. Use of injectable biomaterials for the repair and augmentation of the anal sphincters
US5573934A (en) 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
WO1993020837A1 (fr) * 1992-04-21 1993-10-28 Ajinomoto Co., Inc. Remede contre les plaies
IL105529A0 (en) 1992-05-01 1993-08-18 Amgen Inc Collagen-containing sponges as drug delivery for proteins
CA2137275A1 (en) * 1992-06-03 1993-12-09 Richard L. Eckert Bandage for continuous application of biologicals
JP3224607B2 (ja) 1992-09-11 2001-11-05 株式会社アズウェル 血液凝固第ｘｉｉｉ因子活性測定方法および該測定用試薬キット
US5433943A (en) 1992-12-21 1995-07-18 Osipow; Lloyd I. Deodorant and/or antiperspirant compositions
US5549904A (en) 1993-06-03 1996-08-27 Orthogene, Inc. Biological adhesive composition and method of promoting adhesion between tissue surfaces
GB9313501D0 (en) 1993-06-30 1993-08-11 Nycomed Imaging As Improvements in or relating to polymer materials
US5939385A (en) 1993-08-13 1999-08-17 Zymogenetics, Inc. Transglutaminase cross-linkable polypeptides and methods relating thereto
US5487895A (en) 1993-08-13 1996-01-30 Vitaphore Corporation Method for forming controlled release polymeric substrate
US5428014A (en) 1993-08-13 1995-06-27 Zymogenetics, Inc. Transglutaminase cross-linkable polypeptides and methods relating thereto
US5441193A (en) 1993-09-23 1995-08-15 United States Surgical Corporation Surgical fastener applying apparatus with resilient film
US5503638A (en) 1994-02-10 1996-04-02 Bio-Vascular, Inc. Soft tissue stapling buttress
JP3433302B2 (ja) 1994-02-21 2003-08-04 株式会社ニチロ 新規ゲル化素材及びその製造法並びにこれを用いたゲル化食品とその製造法
US6704210B1 (en) 1994-05-20 2004-03-09 Medtronic, Inc. Bioprothesis film strip for surgical stapler and method of attaching the same
JPH07328108A (ja) * 1994-06-10 1995-12-19 Ajinomoto Co Inc 生体組織接着剤及び血液凝固剤
NZ291414A (en) 1994-08-26 1998-05-27 Novo Nordisk As Microbial transglutaminases and methods of production using fungi and dna constructs
US5931165A (en) 1994-09-06 1999-08-03 Fusion Medical Technologies, Inc. Films having improved characteristics and methods for their preparation and use
EP0745670B1 (en) 1994-10-11 2004-06-23 Ajinomoto Co., Inc. Stabilized transglutaminase and enzymatic preparation containing the same
FR2726571B1 (fr) * 1994-11-03 1997-08-08 Izoret Georges Colle biologique, procede de preparation et dispositif d'application pour colle biologique, et durcisseurs pour colle biologique
FI972443A7 (fi) 1994-12-07 1997-06-09 Novozymes As Polypeptidi, jonka allergeenisuus on vähentynyt
JP4223548B2 (ja) 1994-12-07 2009-02-12 ジ・アメリカン・ナショナル・レッド・クロス 補足または非補足組織シーラント、それらの製法および使用
CA2208730A1 (en) 1995-01-19 1996-07-25 Novo Nordisk A/S Transglutaminases from oomycetes
JP3669390B2 (ja) 1995-02-09 2005-07-06 味の素株式会社 バチルス属細菌由来のトランスグルタミナーゼ
US5900245A (en) 1996-03-22 1999-05-04 Focal, Inc. Compliant tissue sealants
WO1996040791A1 (en) 1995-06-07 1996-12-19 Novo Nordisk A/S Modification of polypeptides
US5810855A (en) * 1995-07-21 1998-09-22 Gore Enterprise Holdings, Inc. Endoscopic device and method for reinforcing surgical staples
US5702409A (en) 1995-07-21 1997-12-30 W. L. Gore & Associates, Inc. Device and method for reinforcing surgical staples
SE504680C2 (sv) 1995-09-19 1997-04-07 Rekordverken Ab Tallrik med fläkt- och kastvingar och urtag för spridning av agnar och boss från en skördetröska
AU7398196A (en) * 1995-10-11 1997-04-30 Fusion Medical Technologies, Inc. Device and method for sealing tissue
JPH09122227A (ja) 1995-10-31 1997-05-13 Bio Eng Lab:Kk 医用材料およびその製造方法
US5752974A (en) 1995-12-18 1998-05-19 Collagen Corporation Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
DE19604706A1 (de) 1996-02-09 1997-08-14 Merck Patent Gmbh Vernetzungsprodukte von Aminogruppen-haltigen Biopolymeren
AU2052197A (en) 1996-02-20 1997-09-02 Fusion Medical Technologies, Inc. Compositions and methods for sealing tissue and preventing post-surgical adhesions
CZ318998A3 (cs) 1996-04-04 1999-09-15 Baxter Aktiengesellschaft Hemostatická houba na bázi kolagenu, způsob její přípravy, kryt na ránu a kit k přípravě tohoto krytu
US6132765A (en) 1996-04-12 2000-10-17 Uroteq Inc. Drug delivery via therapeutic hydrogels
US5834232A (en) 1996-05-01 1998-11-10 Zymogenetics, Inc. Cross-linked gelatin gels and methods of making them
CA2251129A1 (en) 1996-05-03 1997-11-13 Innogenetics N.V. New medicaments containing gelatin cross-linked with oxidized polysaccharides
JP3407599B2 (ja) 1996-07-01 2003-05-19 味の素株式会社 接着用酵素製剤及び接着食品の製造法
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6706690B2 (en) 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
US6063061A (en) 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US7320962B2 (en) 1996-08-27 2008-01-22 Baxter International Inc. Hemoactive compositions and methods for their manufacture and use
ZA978537B (en) 1996-09-23 1998-05-12 Focal Inc Polymerizable biodegradable polymers including carbonate or dioxanone linkages.
US5752965A (en) 1996-10-21 1998-05-19 Bio-Vascular, Inc. Apparatus and method for producing a reinforced surgical fastener suture line
JP2001511162A (ja) 1997-02-06 2001-08-07 ノボ ノルディスク アクティーゼルスカブ 付加され、そして／又は除去された付着基を有するポリペプチド−ポリマー結合体
US6371975B2 (en) 1998-11-06 2002-04-16 Neomend, Inc. Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers
DE19882746T1 (de) 1997-04-03 2001-10-18 California Inst Of Techn Enzymvermittelte Modifikation von Fibrin für das Gewebs-Engineering
WO1998051711A1 (fr) 1997-05-14 1998-11-19 Japan As Represented By Director General Of National Institute Of Sericultural And Entomological Science Ministry Of Agriculture, Forestry And Fisherries Perles de chitine, perles de chitosane, leur procede de production, vehicule comprenant lesdites perles, et procede de preparation d'une spore de microsporidie
US6458386B1 (en) 1997-06-03 2002-10-01 Innogenetics N.V. Medicaments based on polymers composed of methacrylamide-modified gelatin
US6015474A (en) 1997-06-20 2000-01-18 Protein Polymer Technologies Methods of using primer molecules for enhancing the mechanical performance of tissue adhesives and sealants
ATE375387T1 (de) 1997-06-25 2007-10-15 Novozymes As Modifiziertes polypeptid
ZA987019B (en) 1997-08-06 1999-06-04 Focal Inc Hemostatic tissue sealants
US6190896B1 (en) 1997-11-14 2001-02-20 Bassam M. Fraij Active human cellular transglutaminase
US6762336B1 (en) 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
WO1999036570A2 (en) 1998-01-20 1999-07-22 Pericor Science Inc Transglutaminase linkage of agents to tissue
US6136341A (en) 1998-02-27 2000-10-24 Petito; George D. Collagen containing tissue adhesive
US6107401A (en) 1998-03-26 2000-08-22 Air Products And Chemicals, Inc. Process for producing amine functional derivatives of poly (vinyl alcohol)
JP4137224B2 (ja) 1998-03-31 2008-08-20 天野エンザイム株式会社 酵素による蛋白質の架橋法
US6428978B1 (en) 1998-05-08 2002-08-06 Cohesion Technologies, Inc. Methods for the production of gelatin and full-length triple helical collagen in recombinant cells
JP4480270B2 (ja) 1998-05-19 2010-06-16 ジ・アメリカン・ナショナル・レッド・クロス 止血サンドウィッチ包帯
US20020015724A1 (en) 1998-08-10 2002-02-07 Chunlin Yang Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing
DE19838189A1 (de) 1998-08-24 2000-03-02 Basf Ag Stabile pulverförmige Vitamin- und Carotinoid-Zubereitungen und Verfahren zu deren Herstellung
US7241730B2 (en) 1998-08-27 2007-07-10 Universitat Zurich Enzyme-mediated modification of fibrin for tissue engineering: fibrin formulations with peptides
FR2784296B1 (fr) * 1998-09-18 2001-01-05 Imedex Biomateriaux Dispositif pour la formulation et la delivrance d'un melange, notamment pour l'application chirurgicale de ce melange
AU6078899A (en) 1998-10-13 2000-05-01 Novozymes A/S A modified polypeptide with reduced immune response
US6899889B1 (en) 1998-11-06 2005-05-31 Neomend, Inc. Biocompatible material composition adaptable to diverse therapeutic indications
US6454787B1 (en) 1998-12-11 2002-09-24 C. R. Bard, Inc. Collagen hemostatic foam
CA2356597A1 (en) 1998-12-28 2000-07-13 Ajinomoto Co., Inc. Process for producing transglutaminase
US6610043B1 (en) 1999-08-23 2003-08-26 Bistech, Inc. Tissue volume reduction
CA2345779A1 (en) 1999-08-27 2001-03-08 Department Of National Defence Hydrogel wound dressing containing liposome-encapsulated therapeutic agent
WO2001028515A1 (en) 1999-10-22 2001-04-26 Líf-Hlaup ehf. Bio-Gels Pharmaceuticals Inc. Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion
US20030035786A1 (en) 1999-11-04 2003-02-20 Medtronic, Inc. Biological tissue adhesives, articles, and methods
US6992172B1 (en) 1999-11-12 2006-01-31 Fibrogen, Inc. Recombinant gelatins
US6425885B1 (en) * 1999-12-20 2002-07-30 Ultradent Products, Inc. Hydraulic syringe
CA2403558A1 (en) 2000-03-23 2001-09-27 Merck & Co., Inc. Thrombin inhibitors
US6682760B2 (en) 2000-04-18 2004-01-27 Colbar R&D Ltd. Cross-linked collagen matrices and methods for their preparation
JP2001329183A (ja) 2000-05-22 2001-11-27 Yuichi Mori ゲル化性組成物
US7108876B2 (en) 2001-01-25 2006-09-19 Nutricepts, Inc. Shaped cheese reconstruction with transglutaminase
US6565530B2 (en) 2001-02-28 2003-05-20 Scimed Life Systems, Inc. Immobilizing objects in the body
JP4051621B2 (ja) 2001-03-30 2008-02-27 味の素株式会社 接着用酵素製剤及び接着成形食品の製造方法。
RU2198684C2 (ru) * 2001-04-06 2003-02-20 Российский научно-исследовательский институт гематологии и трансфузиологии Гемостатическая губка и способ ее получения
WO2002085422A1 (en) 2001-04-25 2002-10-31 Eidgenössische Technische Hochschule Zürich Drug delivery matrices to enhance wound healing
US6656193B2 (en) 2001-05-07 2003-12-02 Ethicon Endo-Surgery, Inc. Device for attachment of buttress material to a surgical fastening device
ATE376410T1 (de) 2001-05-16 2007-11-15 Susanna Elizabeth Chalmers Wundverbände und wundbehandlungszusammensetzungen
EP1419187A4 (en) 2001-06-01 2006-06-07 Shriners Hospitals Children COMPOSITIONS BASED ON POLYMER COMPOSITES
US8741335B2 (en) 2002-06-14 2014-06-03 Hemcon Medical Technologies, Inc. Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan
GB2377939B (en) 2001-07-26 2005-04-20 Johnson & Johnson Medical Ltd Apertured sheet materials
US8501165B2 (en) 2001-12-12 2013-08-06 Promethean Surgical Devices Llc In situ bonds
US6939358B2 (en) 2001-12-20 2005-09-06 Gore Enterprise Holdings, Inc. Apparatus and method for applying reinforcement material to a surgical stapler
JP4489437B2 (ja) 2002-02-21 2010-06-23 エンセル，インコーポレイテッド 表面コーティングとしての固定化生物活性ヒドロゲルマトリックス
US7101695B2 (en) * 2002-03-01 2006-09-05 Szu-Yi Chou Method of producing transglutaminase having broad substrate activity
WO2003074004A2 (en) 2002-03-01 2003-09-12 Szu-Yi Chou Method of producing antigens
EP1494730B1 (en) * 2002-03-22 2012-01-18 Kuros Biosurgery AG Composition for hard tissue augmentation
US7005143B2 (en) 2002-04-12 2006-02-28 3M Innovative Properties Company Gel materials, medical articles, and methods
WO2003088844A1 (en) 2002-04-15 2003-10-30 Cook Biotech Incorporated Apparatus and method for producing a reinforced surgical staple line
WO2003104313A1 (en) 2002-06-11 2003-12-18 Terminus Biotech Ab Porous gelatin material, gelatin structures, methods for preparation of the same and uses thereof
US20070082023A1 (en) 2002-06-14 2007-04-12 Hemcon Medical Technologies, Inc. Supple tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan
US20040106344A1 (en) 2002-06-28 2004-06-03 Looney Dwayne Lee Hemostatic wound dressings containing proteinaceous polymers
US6773156B2 (en) 2002-07-10 2004-08-10 Tah Industries, Inc. Method and apparatus for reducing fluid streaking in a motionless mixer
AU2002950340A0 (en) 2002-07-23 2002-09-12 Commonwealth Scientific And Industrial Research Organisation Biodegradable polyurethane/urea compositions
DE60312525T2 (de) 2002-08-09 2007-12-06 Ottawa Health Research Institute, Ottawa Biosynthetische matrix und deren verwendung
DE10261126A1 (de) 2002-08-13 2004-03-04 Aventis Behring Gmbh Lagerungsstabile, flüssige Fibrinogen-Formulierung
US20060155234A1 (en) 2002-09-10 2006-07-13 American National Red Cross Hemostatic dressing
AU2003275289A1 (en) * 2002-09-26 2004-04-19 University Of Maryland Baltimore County Polysaccharide-based polymers and methods of making the same
CN100448366C (zh) 2002-09-26 2009-01-07 味之素株式会社 酶制剂及用其生产食品的方法
WO2004028404A2 (en) * 2002-09-30 2004-04-08 Fibrogen, Inc. Dry tissue sealant compositions
GB2393656B (en) 2002-10-01 2005-11-16 Johnson & Johnson Medical Ltd Enzyme-sensitive therapeutic wound dressings
WO2004042068A2 (en) * 2002-10-31 2004-05-21 Northwestern University Injectable and bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation
US6863783B2 (en) 2002-11-14 2005-03-08 The Meow Mix Company Method of producing electrostatically charged gelatin
US7718556B2 (en) 2002-12-16 2010-05-18 Gunze Limited Medical film
WO2005051979A1 (en) 2003-02-21 2005-06-09 Akzo Nobel N.V. Prevention and/or delay of peptide/protein carbamylation in urea solutions utilizing non-ethylene diamine like compounds
JP2004283371A (ja) 2003-03-20 2004-10-14 Nagoya Industrial Science Research Inst 医用材料
US7019191B2 (en) 2003-03-25 2006-03-28 Ethicon, Inc. Hemostatic wound dressings and methods of making same
US6923996B2 (en) 2003-05-06 2005-08-02 Scimed Life Systems, Inc. Processes for producing polymer coatings for release of therapeutic agent
EP1628529A2 (en) 2003-05-30 2006-03-01 Nederlandse Organisatie voor Toegepast- Natuurwetenschappelijk Onderzoek Inducible release vehicles
US7129210B2 (en) 2003-07-23 2006-10-31 Covalent Medical, Inc. Tissue adhesive sealant
US7186684B2 (en) 2003-08-07 2007-03-06 Ethicon, Inc. Hemostatic device containing a protein precipitate
US7316822B2 (en) 2003-11-26 2008-01-08 Ethicon, Inc. Conformable tissue repair implant capable of injection delivery
WO2005055958A2 (en) 2003-12-09 2005-06-23 Promethean Surgical Devices Llc Improved surgical adhesive and uses therefor
US20080026444A1 (en) 2003-12-24 2008-01-31 Shionogi & Co., Ltd. Process For Producing Protein-Polymer Complex
US7109163B2 (en) 2004-01-30 2006-09-19 Ethicon, Inc. Hemostatic compositions and devices
US20050209441A1 (en) * 2004-03-22 2005-09-22 Lile Jackson D Process for promoting proper folding of human serum albumin using a human serum albumin ligand
US20050271727A1 (en) 2004-06-07 2005-12-08 Callisyn Pharmaceuticals, Inc. Biodegradable and biocompatible crosslinked polymer hydrogel prepared from PVA and/or PEG macromer mixtures
US7468350B2 (en) 2004-06-16 2008-12-23 Pneumrx, Inc. Glue composition for lung volume reduction
CA2570261C (en) 2004-07-08 2014-06-10 Pneumrx, Inc. Pleural effusion treatment device, method and material
JP4994230B2 (ja) 2004-07-08 2012-08-08 ヌームアールエックス・インコーポレーテッド 密封機能を備える肺装置
US7766891B2 (en) 2004-07-08 2010-08-03 Pneumrx, Inc. Lung device with sealing features
US20080241878A1 (en) 2004-08-12 2008-10-02 Johannes Wilhelmus Leonardus Boumans Method For Enzmatic Cross-Linking Of A Protein, Cross-Linked Protein Thus Obatained And Use Thereof
GB0420091D0 (en) 2004-09-10 2004-10-13 Univ Nottingham Trent Medical implant materials
US20060100138A1 (en) 2004-11-10 2006-05-11 Olsen David R Implantable collagen compositions
FR2878533B1 (fr) 2004-11-26 2007-04-27 Univ Cergy Pontoise Biomateriau capable d'effectuer successivement une transition solution/gel puis une transition gel/solution
JP2008529663A (ja) 2005-02-09 2008-08-07 チルドレンズ メディカル センター コーポレイション 組織回復のために流体を混合および供給するデバイス
US20080107703A1 (en) 2005-02-14 2008-05-08 Yasuhiko Tabata Hydrogel For Medical Use
US7485323B2 (en) 2005-05-31 2009-02-03 Gelita Ag Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions
MX2007015676A (es) 2005-06-15 2008-02-20 Novo Nordisk Healthcare Ag Conjugacion de la hormona de crecimiento mediada por transglutaminasa.
WO2007126411A2 (en) 2005-07-28 2007-11-08 Carnegie Mellon University Biocompatible polymers and methods of use
DE102005054940A1 (de) 2005-11-17 2007-05-24 Gelita Ag Verbundmaterial, insbesondere für die medizinische Anwendung , und Verfahren zu dessen Herstellung
AU2006321913B2 (en) 2005-12-06 2012-08-02 Covidien Lp Biocompatible tissue sealants and adhesives
CA2573472A1 (en) 2006-01-23 2007-07-23 Tyco Healthcare Group Lp Biodegradable hemostatic compositions
US20070246505A1 (en) 2006-04-24 2007-10-25 Medical Ventures Inc. Surgical buttress assemblies and methods of uses thereof
KR20070104748A (ko) 2006-04-24 2007-10-29 박현진 어류 젤라틴 하드 캅셀용 필름 형성 조성물 및 이의제조방법
EP2021536B1 (en) 2006-04-24 2014-02-26 Coloplast A/S Non-woven structures produced by a non-toxic dry solvent spinning process
WO2007134118A2 (en) 2006-05-09 2007-11-22 Chulso Moon Protein based composition and methods of using same
WO2008000655A2 (de) 2006-06-27 2008-01-03 Robert Bosch Gmbh Verfahren und vorrichtung zur vermeidung von störungen eines funkübertragungssystems
DE102006033168A1 (de) 2006-07-10 2008-01-17 Gelita Ag Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung einer vernetzenden therapeutischen Zusammensetzung
DE102006033167A1 (de) * 2006-07-10 2008-01-24 Gelita Ag Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung eines vernetzenden medizinischen Klebers
TWI436793B (zh) 2006-08-02 2014-05-11 巴克斯特國際公司 快速作用之乾密封膠及其使用和製造方法
JP2010512230A (ja) 2006-12-11 2010-04-22 プルーロームド インコーポレイテッド 灌流臓器止血法
US8133484B2 (en) * 2006-12-15 2012-03-13 Lifebond Ltd Hemostatic materials and dressing
BRPI0718328A2 (pt) * 2006-12-15 2011-10-11 Lifebond Ltd composição, curativo hemostático e dispositivo médico para a inserção em um corpo de um ser humano ou de um mamìfero inferior
US8088095B2 (en) 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
EP2125092A4 (en) 2007-02-22 2012-03-14 Pluromed Inc USE OF REVERSIBLE HEAT-SENSITIVE POLYMERS FOR FLOW CONTROL OF A BIOLOGICAL LIQUID AFTER MEDICAL USE
BRPI0814439B1 (pt) 2007-07-20 2018-12-11 Imaflex, Inc. filme de palha, filme para fumigação e/ou filme para propagação, seu processo de produção e seu uso
US8529897B2 (en) 2007-08-16 2013-09-10 Carnegie Mellon University Inflammation-regulating compositions and methods
US8221783B2 (en) 2007-09-10 2012-07-17 Boston Scientific Scimed, Inc. Medical devices with triggerable bioadhesive material
US20110104052A1 (en) 2007-12-03 2011-05-05 The Johns Hopkins University Methods of synthesis and use of chemospheres
EP2254610A4 (en) 2008-02-22 2013-07-31 Dermal Technologies Llc COMPOSITIONS FOR TISSUE REINFORCEMENT
US20100008989A1 (en) * 2008-06-12 2010-01-14 Ishay Attar Process for manufacture of gelatin solutions and products thereof
WO2009153748A2 (en) 2008-06-18 2009-12-23 Lifebond Ltd Methods and devices for use with sealants
EP2543394A1 (en) 2008-06-18 2013-01-09 Lifebond Ltd A method for enzymatic cross-linking of a protein
EP2487206A3 (en) * 2008-06-18 2012-11-28 Lifebond Ltd Cross-linkable gelatin-based compositions
WO2010027471A2 (en) 2008-09-04 2010-03-11 The General Hospital Corporation Hydrogels for vocal cord and soft tissue augmentation and repair
WO2011077388A1 (en) * 2009-12-22 2011-06-30 Lifebond Ltd Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
US9297464B1 (en) * 2014-09-11 2016-03-29 Beto Engineering & Marketing Co., Ltd. Air pump having pivotal attachment

Also Published As

Publication number Publication date
CA2672651A1 (en) 2008-06-26
JP2012110724A (ja) 2012-06-14
RU2464015C2 (ru) 2012-10-20
CA2672651C (en) 2014-03-11
WO2008076407A3 (en) 2010-01-28
KR101428122B1 (ko) 2014-08-07
CN102552967B (zh) 2015-08-12
US20100063459A1 (en) 2010-03-11
JP5993571B2 (ja) 2016-09-14
KR20090095647A (ko) 2009-09-09
JP2010521994A (ja) 2010-07-01
BRPI0718328A2 (pt) 2011-10-11
AU2007334394A1 (en) 2008-06-26
CN102552967A (zh) 2012-07-11
CN103933606A (zh) 2014-07-23
US9017664B2 (en) 2015-04-28
US20150196683A1 (en) 2015-07-16
EP2111239A2 (en) 2009-10-28
RU2009122941A (ru) 2011-01-20
HK1148488A1 (en) 2011-09-09
US8722039B2 (en) 2014-05-13
MX2009006369A (es) 2010-02-24
EP2111239B1 (en) 2013-03-06
WO2008076407A2 (en) 2008-06-26
CN101854960B (zh) 2014-06-25
AU2007334394B2 (en) 2013-06-06
US20150273103A1 (en) 2015-10-01
CN101854960A (zh) 2010-10-06
CN103933606B (zh) 2016-08-24
US9655988B2 (en) 2017-05-23
US9636433B2 (en) 2017-05-02
US20120226211A1 (en) 2012-09-06

Similar Documents

Publication Publication Date Title
JP5581056B2 (ja) ゼラチン−トランスグルタミナーゼ止血ドレッシング及びシーラント
EP2586467B1 (en) Gelatin-transglutaminase hemostatic dressings and sealants
US20060258560A1 (en) Dry tissue sealant compositions
JP2004174223A (ja) アルデヒド変性した多糖類および止血物質を含有している止血用の傷用包帯
JP2000510357A (ja) コラーゲンを基にした止血スポンジ
US11484623B2 (en) Dry pad comprising thrombin and pectin
Foster Bioadhesives as surgical sealants: A Review
HK1148488B (en) Gelatin-transglutaminase hemostatic dressings and sealants

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20100416

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101209

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20101209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111206

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111207

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20120705

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20120709

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130108

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20130327

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130410

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140227

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140624

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140714

R150 Certificate of patent or registration of utility model

Ref document number: 5581056

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250